| Market Capitalization (Millions $) |
454,889 |
| Shares
Outstanding (Millions) |
1,774 |
| Employees |
57,000 |
| Revenues (TTM) (Millions $) |
62,819 |
| Net Income (TTM) (Millions $) |
3,641 |
| Cash Flow (TTM) (Millions $) |
4,216 |
| Capital Exp. (TTM) (Millions $) |
1,244 |
Business Description
AbbVie Inc. is a global, research-based biopharmaceutical company that was established in 2013 following a separation from Abbott Laboratories. The companys mission revolves around leveraging its scientific expertise, dedicated workforce, and innovative approaches to develop and market advanced therapies that target some of the world’s most intricate and challenging diseases. AbbVie is committed to addressing significant health issues through continuous research and development.
Key Areas of Focus
1. Pharmaceutical Products: AbbVie focuses on developing and marketing innovative pharmaceuticals. The company markets its pharmaceutical products primarily in the United States and sells them directly to wholesalers, government agencies, healthcare facilities, and independent retailers from its distribution centers. Marketing efforts are aimed at encouraging healthcare providers to prescribe AbbVie’s branded products. Key customer segments include managed care organizations, pharmacy benefit managers, as well as state and federal government agencies, including the Department of Veterans Affairs and the Department of Defense.
2. Diagnostic Products: Although primarily a pharmaceutical company, AbbVie also has a segment dedicated to diagnostics. Through its strategic alliance with Celera Diagnostics, AbbVie develops, manufactures, and markets a range of in vitro molecular diagnostic products intended for disease detection, monitoring disease progression, and aiding in therapy selection. In Europe and Japan, AbbVie distributes diagnostic tests for detecting bovine spongiform encephalopathy (BSE) in cattle through an agreement with Enfer Scientific Ltd.
3. Global Distribution: The companys diagnostic products are marketed globally. They are directly marketed and sold to hospitals, labs, clinics, and physicians offices from AbbVie-owned distribution centers or through local distributors, depending on the region. The company also sells blood glucose monitoring tools directly to consumers.
4. Hospital Products: AbbVie’s Hospital Products segment includes a variety of medical products, such as venipuncture supplies and other sundry items. The majority of these products are marketed in the U.S. distributed from its facilities to wholesalers, hospitals, integrated delivery networks, and other patient care locations.
Competitive Landscape
AbbVie faces significant competition across its various segments:
- Pharmaceutical Products: Competition arises from other healthcare and pharmaceutical companies. A key competitive aspect is the race for technological innovation. Rapid advancements and introductions of new products by competitors can lead to product obsolescence. Additionally, pricing pressure and the introduction of generic drugs have heightened competition in this market.
- International Competition: Similar dynamics are observed in the international segments, where competition stems from both healthcare manufacturers and pharma companies. The focus on innovation remains a crucial factor, along with pricing strategies.
- Nutritional Products: In the nutritional space, competition comes from various healthcare manufacturers and food companies, influenced by pricing, scientific advancements, and promotional initiatives.
- Hospital Products: Competitors in this segment emphasize technological innovation, pricing, ease of use, service performance, and overall product effectiveness. Rapid changes in technology can affect product relevance and market positioning.
Conclusion
AbbVie Inc. stands as a significant player in the biopharmaceutical industry, dedicated to advancing health outcomes through its innovative therapies and products. The company operates under a challenging competitive environment, characterized by rapid technological changes and pressing market demands, necessitating continuous innovation and adaptation to maintain its leadership.
Company Address: 1 North Waukegan Road North Chicago 60064 IL
Company Phone Number: 932-7900 Stock Exchange / Ticker: NYSE ABBV
|
1.75% 
6.83 %